sch 28080 has been researched along with nifedipine in 1 studies
Studies (sch 28080) | Trials (sch 28080) | Recent Studies (post-2010) (sch 28080) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
---|---|---|---|---|---|
217 | 0 | 20 | 16,024 | 2,496 | 1,505 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyreis, M; Fürst, J; Gaisberger, M; Hauser-Kronberger, C; Jakab, M; Ketterl, N; Kiesslich, T; Kittl, M; Ritter, M | 1 |
1 other study(ies) available for sch 28080 and nifedipine
Article | Year |
---|---|
The H+/K+ ATPase Inhibitor SCH-28080 Inhibits Insulin Secretion and Induces Cell Death in INS-1E Rat Insulinoma Cells.
Topics: Animals; Apoptosis; Calcium; Cell Line, Tumor; Cell Size; Cell Survival; Colon; Enzyme-Linked Immunosorbent Assay; Glucose; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Imidazoles; Insulin; Insulin Secretion; Insulinoma; KATP Channels; Membrane Potentials; Nifedipine; Patch-Clamp Techniques; Phosphatidylserines; Proton Pump Inhibitors; Rats; RNA, Messenger | 2017 |